[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004206:Disopyramide / Q000627:therapeutic use; D016700:Encainide; D005424:Flecainide; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D011427:Propiophenones; D011405:Propafenone; D004206:Disopyramide; D011802:Quinidine; D005424:Flecainide; D011342:Procainamide; D016700:Encainide